Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/135882
Title: TARGETING THE PIK3 PATHWAY IN NON-SMALL CELL LUNG CANCER
Authors: DANIEL TAN SHAO WENG
Keywords: PI3K pathway, EGFR mutant NSCLC, TKI resistance
Issue Date: 1-Jun-2016
Citation: DANIEL TAN SHAO WENG (2016-06-01). TARGETING THE PIK3 PATHWAY IN NON-SMALL CELL LUNG CANCER. ScholarBank@NUS Repository.
Abstract: The phosphotidyl inositol (3) kinase (PI3K) pathway is a critical survival pathway that is subverted in many cancers, particularly those that are receptor tyrosine kinase driven. This thesis describes a multi-pronged approach to examine the relevance of this pathway in epidermal growth factor receptor mutation positive lung adenocarcinoma, the commonest subtype in Singapore. I used a combination of integrative genomics and other molecular assays to describe the prevalence of PI3K pathway alterations in our local population (Tan, IJC 2014). I further evaluated the role of PI3K inhibition in the clinic, gaining significant insights to the challenges in developing this class of compounds (Tan, ASCO Proceedings 2014), and generated a range of preclinical models to inform on the potential therapeutic niches. Finally, with expanding knowledge on intra-tumoral heterogeneity, I present the case for high precision genomic interrogation, in order to delineate mutational context to predict therapeutic vulnerabilities (Tan, WCLC 2015).
URI: http://scholarbank.nus.edu.sg/handle/10635/135882
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
TanDSW_PhDThesis.pdf18.31 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.